PAVmed
PAVM
14 hedge funds and large institutions have $829K invested in PAVmed in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
56% more funds holding
Funds holding: 9 → 14 (+5)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.02% less ownership
Funds ownership: 0.02% → 0.01% (-0.02%)
51% less capital invested
Capital invested by funds: $1.69M → $829K (-$860K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$373K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$95.8K |
| 3 |
Renaissance Technologies
New York
|
+$61K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$42.1K |
| 5 |
Millennium Management
New York
|
+$33.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.33M |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$206K |
| 3 |
Jane Street
New York
|
-$17K |
| 4 |
Morgan Stanley
New York
|
-$2.44K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
-$2K |
PAVM Hedge Fund Activity: Q3 2018 in Review
14 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2018, worth a combined $829K — down 51% from $1.69M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PAVM positions and 4 closed out — a net gain of 5 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $373K. The largest seller was Sabby Management, exiting entirely with an estimated $1.33M sold.
- 14 institutional investors held PAVmed (PAVM) as of Q3 2018, up from 9 in Q2 2018.
- Funds reported $829K of PAVmed stock for Q3 2018, down 51% quarter-over-quarter.
- 9 funds opened new PAVmed positions in Q3 2018 and 4 closed out, a net change of +5 holders.
- The largest PAVmed buyer in Q3 2018 was Vanguard Group, an estimated $373K added.
- The largest PAVmed seller in Q3 2018 was Sabby Management, an estimated $1.33M sold.
Based on aggregated 13F filings for Q3 2018.